Loading
Corbus Pharmaceuticals Holdings, Inc. Stock: price and insider trades · United States
1 insider bought €22k of shares over the last 90 days, the latest by Saxena Nishant C, filed 12 Aug 2026.
Corbus Pharmaceuticals Holdings, Inc.: what insiders have been doing
Corbus Pharmaceuticals Holdings, Inc., classified in the Health Care sector, is a listed company based in Norwood, United States, founded in 2009. Its insiders report their share dealings to SEC (Form 4). From 23 October 2025 to 23 October 2026, the disclosure feed for Corbus Pharmaceuticals Holdings, Inc. logged 35 filings by 15 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €22k) and 16 sales (9 insiders, €1.4M). Netting one side against the other leaves €1.4M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a sale of €294k by Cormorant Asset Management, LP, published on 15 December 2025. Among those who bought: 1 senior executive.
Across the 3,167 companies tracked on its exchange, the median is 24 filings; at 35 filings, this issuer sits above that mark. Looking back to 2016, when coverage begins, insiders filed 107 purchases and 37 sales.
The clock since the last published purchase (12 August 2026) now reads 73 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
208
Thresholds
n/a
Buy Volume
€51M
107 ops. · all time
Sell Volume
€5M
37 ops. · all time
Who traded when
BuySaleYuval Cohen5 sales
Sean F. Moran4 sales
Anne Altmeyer3 sales
Smethurst Dominic3 sales
Ian Hodgson2 sales
John Kenneth Jenkins2 sales
+4 other insiders
Since the insiders bought
- -7.1%Entry US$47.36 · Close at T+30 US$44.00
- -43.1%Entry US$21.35 · Close at T+365 US$12.14
- -15.1%Entry US$7.71 · Close at T+365 US$6.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Corbus Pharmaceuticals Holdings, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$34.03.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$4.42
Analyst consensus
10 analystsStrong buy
US$17.25Target US$34.03(+670%)US$48.00
Income statement
EBITDA-US$78.3M
Net income-US$78.5M0.0% margin
Valuation
PER (forward)-0.8x
P/Book0.8x
Beta2.63
Balance sheet & cash
Market capUS$85.5M
Total debtUS$1.6M
Free Cash Flow-US$64.5M
Debt / Equity4%
Profitability & ownership
ROE-95.6%
ROA-53.0%
% insiders1.2%
% institutions83.6%
Last declaration on 15 September 2026
Declarations208 total
2,000 shares@ US$7.84150.017% mcap100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-392093:0
58,333 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-354145:0
2,600 shares@ US$9.62940.0015% mcap100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-346966:0
Canonical exit: 9 Nov 2026 (T+90)
17,000 shares@ US$10.08210.086% mcap23.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-342485:0
12,000 shares@ US$10.08090.061% mcap33.4% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-342479:0
17,000 shares@ US$10.08210.086% mcap58.6% of flowCommon StockSEC144:0001972481-26-000254
12,000 shares@ US$10.08090.061% mcap41.4% of flowCommon StockSEC144:0001972481-26-000255
23,025 shares@ US$9.19950.013% mcap63.7% of flowCommon StockSEC144:0001972481-26-000237
2,026 shares@ US$7.9137100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267672:0
2,412 shares@ US$7.913734.2% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267655:0
4,800 shares@ US$7.913764.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-267671:0
58,300 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-237103:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234851:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234850:0
7,500 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234813:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234853:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234857:0
3,800 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-234860:0
6,097 shares@ US$8.299414.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-091647:0
847 shares@ US$7.38324.2% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-057174:0
13,871 shares@ US$7.782614.5% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-057159:0
4,701 shares@ US$7.7839.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-057168:0
2,415 shares@ US$8.089975.8% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-037643:0
3,285 shares@ US$8.08987.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001193125-26-037647:0
28,365 shares0Common Stock, par value $0.0001 per shareSEC:0001193125-26-015430:0
25 of 208 declarations
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing treatments for inflammatory and fibrotic diseases. It is listed on NASDAQ under the ticker CRBP.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
